Schulte-Sasse U, Hess W, Markschies-Hornung A, Tarnow J
Thorac Cardiovasc Surg. 1983 Oct;31(5):261-5. doi: 10.1055/s-2007-1021993.
The effects of intravenous (iv) nifedipine (7.5 micrograms/kg over 10 min) on systemic hemodynamics and myocardial contractility were investigated under steady state conditions of halothane anesthesia (0.5 MAC) in 8 patients scheduled for elective coronary artery bypass surgery. All patients received long-term medication in the form of beta adrenergic receptor blockers and had a normal global left ventricular function at rest. Halothane produced a marked reduction in left ventricular contractility as documented by a considerable fall in LV max dP/dt. Nifedipine caused a small additional depression of LV max dP/dt without affecting LVEDP significantly. The slight myocardial depressant effect of nifedipine was counterbalanced by a concomitant reduction in left ventricular afterload due to a decrease in the systemic vascular resistance resulting in unchanged or even improved cardiac output. The results indicate that iv nifedipine in the doses used here is safe for patients with ischemic heart disease, even in the presence of already compromised myocardial contractility due to halothane anesthesia and chronic low-dose beta blocker therapy.
在8例择期冠状动脉搭桥手术患者中,于氟烷麻醉(0.5MAC)稳态条件下,研究了静脉注射硝苯地平(10分钟内7.5微克/千克)对全身血流动力学和心肌收缩力的影响。所有患者均接受β肾上腺素能受体阻滞剂形式的长期药物治疗,静息时左心室整体功能正常。氟烷使左心室收缩力显著降低,左心室最大dp/dt大幅下降即证明了这一点。硝苯地平使左心室最大dp/dt略有额外降低,但对左心室舒张末期压力无明显影响。硝苯地平轻微的心肌抑制作用被全身血管阻力降低导致的左心室后负荷同时降低所抵消,从而使心输出量保持不变甚至增加。结果表明,此处所用剂量的静脉注射硝苯地平对缺血性心脏病患者是安全的,即使存在因氟烷麻醉和慢性低剂量β受体阻滞剂治疗而已经受损的心肌收缩力。